Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nodule Cysteine-Rich peptide 273 (NCR273) is a small, secreted, cysteine-rich polypeptide originally identified in the root nodules of the legume Medicago truncatula. It belongs to a large family of over 300 defensin-like peptides that regulate the symbiotic relationship with nitrogen-fixing rhizobia by inducing their terminal differentiation into bacteroids. NCR273 has gained attention in biotechnology for its potent, broad-spectrum antimicrobial and antifungal properties, demonstrating the ability to rapidly kill various pathogens, including antibiotic-resistant bacteria and fungi like Fusarium graminearum. Its mechanism of action involves the disruption of both the outer and inner bacterial membranes, leading to a loss of membrane potential and cell death. As a potential therapeutic agent, NCR273 is being investigated for the treatment of human and animal infections, offering a novel scaffold for the development of next-generation antibiotics.
Disruption of bacterial membrane integrity and inhibition of fungal spore germination
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nodule Cysteine-Rich peptide 273 (NCR273).